Biomet’s revised earnings show much wider losses than previously reported

Tue, 09/03/2013 - 8:59am
Mass Device

Annual losses at Biomet increase dramatically in a revised earnings release for the Warsaw, Ind.-based orthopedics maker.

Biomet loses royalties dispute with spine surgeon

Biomet amended its Q4 and annual earnings report to reflect a swing to red in Q4 and much deeper losses for the full year compared to earlier reports.

The Warsaw, Ind.-based orthopedics company posted losses of $221.2 million on $784 million in sales during the 3-month period ended May 31, 2013. An initial earnings report released in July had reported a $20.5 million profit for the quarter.


Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.